ZHONGSHENGYAOYE(SZ:002317) Xin Lang Cai Jing·2025-10-17 03:04Group 1 - The core viewpoint of the news is that Zhongsheng Pharmaceutical experienced a stock price increase of 5.09%, reaching 17.96 CNY per share, with a trading volume of 733 million CNY and a turnover rate of 5.46%, resulting in a total market capitalization of 15.265 billion CNY [1] - Zhongsheng Pharmaceutical, established on December 31, 2001, and listed on December 11, 2009, is primarily engaged in the research, production, and sales of pharmaceuticals. The revenue composition includes 53.03% from traditional Chinese medicine sales, 38.12% from chemical drug sales, 6.13% from Chinese medicinal materials and decoction pieces, 2.14% from raw materials and intermediates, and 0.58% from other sources [1] Group 2 - From the perspective of fund holdings, one fund under Debang Fund has a significant position in Zhongsheng Pharmaceutical. The Debang Technology Innovation One-Year Open Mixed A Fund (009432) held 218,900 shares in the second quarter, accounting for 4.78% of the fund's net value, making it the fourth-largest holding. The estimated floating profit today is approximately 190,400 CNY [2] - The Debang Technology Innovation One-Year Open Mixed A Fund (009432) was established on November 24, 2020, with a latest scale of 59.358 million CNY. Year-to-date returns are 44.95%, ranking 1217 out of 8160 in its category; the one-year return is 63.3%, ranking 591 out of 8021; and since inception, the return is 10.26% [2]